Depression is a broad and heterogeneous diagnosis. Major depressive disorder (MDD) is characterized by discrete episodes of at least 2 weeks’ duration involving changes in affect, cognition, and neurovegetative functions and inter-episode remissionsThe clinical course of MDD after the initial depressive episode varies from patient to patient. The optimal outcome for a patient with MDD is a full recovery from the major depressive episode and never becoming depressed again. However, patients with MDD in remission can experience residual symptoms, including functional and cognitive impairment, which can increase the risk of relapse. This slide deck covers the course, natural history, and prognosis of MDD.

This slide deck was developed by Professor Dr. Brenda Penninx, Amsterdam UMC, Vrije Universiteit, Department of Psychiatry, The Netherlands; and Professor Dr. Lakshmi Yatham, Department of Psychiatry, University of British Columbia, Canada, in collaboration with Cambridge (a division of Prime, Cambridge, UK).

Index for
slide deck

Introduction

Major depressive disorder (MDD) - Course, natural history and prognosis
Major depressive disorder (MDD) - Course, natural history and prognosis
file_download Download slide in HQ
Depression
Depression

Depression can be defined based on the World Health Organization’s ICD-11 classification system or the American Psychiatric Association’s DSM-5-TR system.

References:
1.National Institute for Health and Care Excellence CG222. Depression in adults: recognition and manageme…

file_download Download slide in HQ
Symptoms of depression
Symptoms of depression

The many symptoms of depression are varied, and can include emotional, cognitive, and physical symptoms that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.1,2

References:
1.American Psychiatric Associa…

file_download Download slide in HQ
Diagnosis of MDD
Diagnosis of MDD

Depression can be diagnosed according to the American Psychiatric Association’s DSM-5-TR criteria, as outlined on the slide.

Reference:
1.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition – text revision. © American Psy…

file_download Download slide in HQ
MDD symptoms in DSM-5-TR
MDD symptoms in DSM-5-TR

The American Psychiatric Association (APA) describes nine depressive symptoms for diagnostic purposes, as outlined on the slide.1 At least five of these symptoms, at least one of which is ‘depressed mood’ or ‘loss of interest or pleasure’ are required during the same two-…

file_download Download slide in HQ
The impact of the symptoms of depression on patients
The impact of the symptoms of depression on patients

As outlined on the slide, the various symptoms of depression can negatively impact a patient’s functioning, including in the areas of work or school, family life, and social life.1,2

References:
1.American Psychiatric Association. Diagnostic and Statistical Manual of Ment…

file_download Download slide in HQ
The course of MDD
The course of MDD

The optimal outcome for a patient with major depressive disorder (MDD) is a full recovery from the major depressive episode and to never become depressed again.5 Treatment of MDD is divided into three phases, corresponding to different stages of the illness.6 Each of thes…

file_download Download slide in HQ
Outcomes for patients with depression
Outcomes for patients with depression

The clinical course of major depressive disorder after the initial depressive episode varies from patient to patient, and whilst roughly half of patients will not go on to experience further recurrence, a minority of patients will experience unremitting depression.1,2

Ref…

file_download Download slide in HQ
Definitions of clinical course and treatment outcomes I
Definitions of clinical course and treatment outcomes I

The terms ‘response’ and ‘remission’ have been used to mean different things in psychiatric research; the most commonly used meanings of these terms in studies of treatment outcomes in people with major depression disorder are given on the slide.1,2

References:
1.Nierenbe…

file_download Download slide in HQ
Definitions of clinical course and treatment outcomes II
Definitions of clinical course and treatment outcomes II

MDD is a chronic disorder, most frequently characterised by relapses and recurrences.2 Relapse can be defined as an episode of MDD that occurs within 6 months of response or remission;2,3 theoretically, relapse signifies the return of a major depressive episode, rather th…

file_download Download slide in HQ
MDD specifiers I
MDD specifiers I

Specifiers are extensions to a diagnosis that further clarify the course, severity, or special features of the disorder.

Reference:
1.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition – text revision. © American Psychia…

file_download Download slide in HQ

Related content

description Article
Treatment-Resistant Depression (TRD) – definition, clinical manifestation, and evidence-based treatment

Treatment-resistant depression (TRD) represents a significant clinical challenge, affecting approximately 30% of individuals with major depressive disorder (MDD) who fail to respond to at least two adequate antidepressant trials.

25.09.2025 Depression
image Image Diagram titled 'Sequential Treatment Optimization Scheme for MDD' showing patient improvement over treatment time across four stages. Stage 1 includes monotherapy, dose optimization, and rTMS; Stage 2 includes augmentation, combination antidepressant, add-on treatment, rTMS/ECT; Stage 3 includes add-on psychopharmacotherapy, switch to tranylcypromine, rTMS/TBS/ECT/VNS; Stage 4 includes repetition or experimental psychopharmacotherapy/brain stimulation. Curved lines represent different patient trajectories, with horizontal dotted lines indicating thresholds for response and remission. Some lines show improvement, while others show little or worsening response over time.
Sequental Treatment Optimization Scheme for Major Depressive Disorder

Sequential treatment optimization scheme for major depressive disorder generated according to international evidence.

18.09.2025 Depression
image Image Infographic titled 'Identification and Effective Management of Factors Potentially Confounding Treatment Response'. It shows eight stacked boxes listing key steps: Check dose and duration of the current antidepressant trial Explore and reduce side effects Consider and treat comorbidities Consider and reduce ongoing stressors Evaluate treatment adherence Pharmacogenomic testing (CYP450) Check and avoid unfavorable medical interaction Evaluate initial therapies and follow recommended treatment algorithm. At the bottom, references are cited (Dold & Kasper, 2017; Kraus et al., 2019), and the image is credited to Neurotorium."
Identification and effective management of factors potentially confounding treatment response

Key steps for managing factors that may confound antidepressant treatment response, including dose, side effects, comorbidities, stressors, adherence, pharmacogenomics, interactions, and treatment algorithms.

18.09.2025 Depression